Ruturaj Masvekar

Government of the United States of America

Also affiliated with Frederick National Laboratory for Cancer Research

MedicineImmunology and MicrobiologyNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Seizure phenotype in CLN3 disease and its relation to other neurologic outcome measures”.

Seizure phenotype in CLN3 disease and its relation to other neurologic outcome measures

Journal of Inherited Metabolic Disease(2021)10.1002/jimd.12366

N/A

0.810DataRank · unranked

10 citations

Sara K. Inati, Ariane Soldatos, Gina Norato, Eva H. Baker, Audrey Thurm +7 more

Enhancing the clinical value of serum neurofilament light chain measurement

JCI Insight(2022)10.1172/jci.insight.161415

N/A

0.780DataRank · unranked

20 citations

Ruturaj Masvekar, Mika Komori, Jonathan A. Phillips, Vighnesh Ramesh, Mihael Varosanec +3 more

Cerebrospinal Fluid Biomarkers of Myeloid and Glial Cell Activation Are Correlated With Multiple Sclerosis Lesional Inflammatory Activity

Frontiers in Neuroscience(2021)10.3389/fnins.2021.649876

N/A

0DataRank · unranked

25 citations

Jonathan A. Phillips, Mika Komori, Tianxia Wu, Bibiana Bielekova, Ruturaj Masvekar

Superiority of serum NFL in predicting Multiple Sclerosis severity

medRxiv(2021)10.1101/2021.05.07.21256836

N/A

0DataRank · unranked

0 citations

Ruturaj Masvekar, Mika Komori, Jonathan A. Phillips, Vighnesh Ramesh, Mihael Varosanec +3 more

Neurofilament light chain in cerebrospinal fluid as a novel biomarker in evaluating both clinical severity and therapeutic response in Niemann-Pick disease type C1

Genetics in Medicine(2022)10.1016/j.gim.2022.11.017

N/A

0DataRank · unranked

34 citations

Nicole Y. Farhat, Ninet Sinaii, An Dang, Changrui Xiao, Elizabeth Berry‐Kravis +6 more

Drug library screen identifies inhibitors of toxic astrogliosis

Multiple Sclerosis and Related Disorders(2022)10.1016/j.msard.2022.103499

N/A

0DataRank · unranked

6 citations

Péter Kósa, Christopher Barbour, Joshua L. Milstein, Bibiana Bielekova, Ruturaj Masvekar

Prognostic Value of Serum/Plasma Neurofilament Light Chain for COVID-19 Associated Mortality

medRxiv(2022)10.1101/2022.01.13.22269244

N/A

0DataRank · unranked

8 citations

Péter Kósa, Kimberly Jin, Kerry Dobbs, Michael Stack, Riccardo Castagnoli +6 more

Neurofilament light chain levels correlate with clinical measures in CLN3 disease

Genetics in Medicine(2020)10.1038/s41436-020-01035-3

N/A

0DataRank · unranked

23 citations

Ninet Sinaii, Ruturaj Masvekar, Eva H. Baker, Audrey Thurm, Ariane Soldatos +4 more

Longitudinal proteomic profiling of cerebrospinal fluid in untreated multiple sclerosis defines evolving disease biology

Nature Communications(2025)10.1038/s41467-025-65154-8

N/A

0DataRank · unranked

1 citations

Shinji Ashida, Keith Lumbard, Jing Wang, Chen Liang, Ruturaj Masvekar +5 more

Idebenone does not inhibit disability progression in primary progressive MS

Multiple Sclerosis and Related Disorders(2020)10.1016/j.msard.2020.102434

N/A

0DataRank · unranked

32 citations

Tianxia Wu, Jonathan A. Phillips, Mika Leinonen, Ruturaj Masvekar, Mika Komori +4 more